Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Diseases (2)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (1)
- Comparative and Laboratory Animal Medicine (1)
- Immunology and Infectious Disease (1)
- Laboratory and Basic Science Research (1)
-
- Life Sciences (1)
- Medical Sciences (1)
- Natural Products Chemistry and Pharmacognosy (1)
- Organic Chemicals (1)
- Organisms (1)
- Other Chemicals and Drugs (1)
- Other Immunology and Infectious Disease (1)
- Pharmacy and Pharmaceutical Sciences (1)
- Therapeutics (1)
- Veterinary Medicine (1)
- Virus Diseases (1)
- Viruses (1)
Articles 1 - 3 of 3
Full-Text Articles in Chemicals and Drugs
The Effects Of Inhibiting Pi3k On Tumor Suppressor Gene P53 And Cell Proliferation, Kelsi Peters
The Effects Of Inhibiting Pi3k On Tumor Suppressor Gene P53 And Cell Proliferation, Kelsi Peters
Undergraduate Theses and Capstone Projects
When the cell surface molecule, Human EGF Receptor (HER2), is overexpressed, the cell can become cancerous. MDA-MB-453 is an established breast cancer cell line made cancerous by HER2 overexpression. This mutation that causes HER2 overexpression affects the cell signaling pathway of phosphoinositide 3-kinase (PI3K), Akt, MDM2, and p53. We predicted that PI3K would be inhibited with the compound, LY294002, sending signals for Akt and MDM2 to be deactivated in MDA-MB-453 cells. Deactivated MDM2 signals for p53 to be activated. P53 is a tumor suppressor protein that exists in low quantities in normal cells, but when damage …
Structure-Based Drug Design Of Novel Therapeutics Targeting Oncostatin M, Kelsey Skluzacek
Structure-Based Drug Design Of Novel Therapeutics Targeting Oncostatin M, Kelsey Skluzacek
Boise State University Theses and Dissertations
At 30% of all new diagnoses, the most prevalent malignancy for women is breast cancer, which in the United States will result in an estimated 266,000 new cases this year alone. Of the patients diagnosed with breast cancer, approximately 10-15% will develop distant metastases within three years of the initial detection of a primary tumor. For comparison, the five-year survival rate for localized breast cancer is 99%, whereas, the survival rate for metastatic breast cancer drops drastically to only 27%. The significant difference in survival rates is indicative of a need for a novel treatment strategy for metastatic breast cancer. …
Paclitaxel Enhances Oncolytic Potential Of Herpes Simplex Virus Type-1 In Cancer Cells, Misagh Naderi
Paclitaxel Enhances Oncolytic Potential Of Herpes Simplex Virus Type-1 In Cancer Cells, Misagh Naderi
LSU Master's Theses
Taxanes are spindle poisons that bind to and stabilize microtubules resulting in mitotic arrest. Herpes simplex Typ-1 (HSV-1) virions utilize the microtubular network for intracellular transport during both virus entry and virus egress from infected cells. It has been reported previously that taxanes may synergize with oncolytic herpes simplex viruses in the treatment of experimental prostate and breast tumors in mice. Other reports have indicated that taxanes may inhibit viral replication in infected cells. In this study the previously characterized Oncolytic Herpes Simplex Virus type 1 (OSVP), which was constructed in Kousoulas lab was used in conjugation with paclitaxel (taxol) …